{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:25:33Z","timestamp":1788963933734,"version":"build-2803163510"},"reference-count":58,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Primary central nervous system lymphoma (PCNSL) is a rare, highly aggressive, extranodal form of non-Hodgkin lymphoma, predominantly diagnosed as primary diffuse large B-cell lymphoma of the central nervous system (CNS DLBCL). Fast and precise diagnosis of PCNSL is critical yet challenging. microRNAs, important regulators in physiology and pathology are potential biomarkers. In 131 patients with CNS DLBCL and with non-malignant brain lesions (n-ML), miR-21, miR-19b and miR-92a, miR-155, miR-196b, miR-let-7b, miR-125b, and miR-9 were examined by RT-qPCR in brain biopsy samples (formalin-fixed paraffin-embedded tissues, FFPET; CNS DLBCL, n = 52; n-ML, n = 42) and cerebrospinal fluid samples (CSF; CNS DLBCL, n = 30; n-ML, n = 23) taken for routine diagnosis. FFPET samples were split into study and validation sets. Significantly higher CSF levels of miR-21, miR-19b, and miR-92a were identified in PCNSL but not in n-ML, and differentiated PCNSL from n-ML with 63.33% sensitivity and 80.77% specificity. In FFPETs, miR-155 and miR-196b were significantly overexpressed and miR-let-7b, miR-125b, and miR-9 were downregulated in PCNSL as compared to n-ML. Combined miR-155 and miR-let-7b expression levels in FFPETs discriminated PCNSL and n-ML with a 97% accuracy. In conclusion, tissue miR-155, miR-196b, miR-9, miR-125b, and miR-let-7b expression profiles differentiate PCNSL from n-ML. PCNSL CSFs and the relevant biopsy samples are characterized by specific, different microRNA profiles. A logistic regression model is proposed to discriminate between PCNSL and non-malignant brain lesions. None of the examined microRNAs influenced overall survival of PCNSL patients. Further ongoing developments involve next generation sequencing-based profiling of biopsy and CSF samples.<\/jats:p>","DOI":"10.3390\/cancers11111647","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T11:05:18Z","timestamp":1572001518000},"page":"1647","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas"],"prefix":"10.3390","volume":"11","author":[{"given":"Michalina","family":"Zajdel","sequence":"first","affiliation":[{"name":"Department of Immunology, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Rymkiewicz","sequence":"additional","affiliation":[{"name":"Flow Cytometry Laboratory, Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sromek","sequence":"additional","affiliation":[{"name":"Department of Immunology, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cieslikowska","sequence":"additional","affiliation":[{"name":"Department of Immunology, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Swoboda","sequence":"additional","affiliation":[{"name":"Department of Immunology, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Kulinczak","sequence":"additional","affiliation":[{"name":"Department of Immunology, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Goryca","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"},{"name":"Core Facilities CeNT, University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Bystydzienski","sequence":"additional","affiliation":[{"name":"Flow Cytometry Laboratory, Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Blachnio","sequence":"additional","affiliation":[{"name":"Flow Cytometry Laboratory, Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Ostrowska","sequence":"additional","affiliation":[{"name":"Department of Lymphoid Malignancies, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Borysiuk","sequence":"additional","affiliation":[{"name":"Flow Cytometry Laboratory, Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Druzd-Sitek","sequence":"additional","affiliation":[{"name":"Department of Lymphoid Malignancies, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4247-2674","authenticated-orcid":false,"given":"Jan","family":"Walewski","sequence":"additional","affiliation":[{"name":"Department of Lymphoid Malignancies, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Chechlinska","sequence":"additional","affiliation":[{"name":"Department of Immunology, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Konrad","family":"Siwicki","sequence":"additional","affiliation":[{"name":"Department of Immunology, Maria Sklodowska-Curie Institute\u2014Oncology Center, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1002\/cncr.30965","article-title":"Diagnosis and management of primary central nervous system lymphoma","volume":"123","author":"Han","year":"2017","journal-title":"Cancer"},{"key":"ref_2","first-page":"300","article-title":"Primary diffuse large B-cell lymphoma of the CNS","volume":"Volume 2","author":"Swerdlow","year":"2017","journal-title":"WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","article-title":"Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma","volume":"23","author":"Abrey","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S1470-2045(15)00076-5","article-title":"European Association for Neuro-Oncology Task Force on Primary, CNS. Lymphoma, Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: Guidelines from the European Association for Neuro-Oncology","volume":"16","author":"Bessell","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/neuonc\/nor203","article-title":"Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)","volume":"14","author":"Sasayama","year":"2012","journal-title":"Neuro-Oncology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1182\/blood-2013-01-476333","article-title":"CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma","volume":"121","author":"Rubenstein","year":"2013","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/neuonc\/nov092","article-title":"CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma","volume":"17","author":"Viaccoz","year":"2015","journal-title":"Neuro-Oncology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bjh.15410","article-title":"Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: A systematic review","volume":"182","author":"Smidt","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fnmol.2013.00039","article-title":"MicroRNAs as biomarkers for CNS disease","volume":"6","author":"Rao","year":"2013","journal-title":"Front. Mol. Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s12035-014-8822-6","article-title":"MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: A Meta-analysis","volume":"51","author":"Wei","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microRNA expression atlas based on small RNA library sequencing","volume":"129","author":"Landgraf","year":"2007","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"JEN.S32843","DOI":"10.4137\/JEN.S32843","article-title":"Role of miRNA-9 in Brain Development","volume":"10","author":"Radhakrishnan","year":"2016","journal-title":"J. Exp. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/gb-2004-5-3-r13","article-title":"Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation","volume":"5","author":"Sempere","year":"2004","journal-title":"Genome Biol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Shao, N.Y., Hu, H.Y., Yan, Z., Xu, Y., Hu, H., Menzel, C., Li, N., Chen, W., and Khaitovich, P. (2010). Comprehensive survey of human brain microRNA by deep sequencing. BMC Genom., 11.","DOI":"10.1186\/1471-2164-11-409"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/neuonc\/nor169","article-title":"Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma","volume":"14","author":"Baraniskin","year":"2012","journal-title":"Neuro-Oncology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/1389202916666150707155610","article-title":"miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma","volume":"16","author":"Mezzolla","year":"2015","journal-title":"Curr. Genom."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-130932","article-title":"MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer\u2019s Disease","volume":"39","author":"Kiko","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/01616412.2016.1250857","article-title":"Identification of the miRNA-mRNA regulatory network in multiple sclerosis","volume":"39","author":"Yang","year":"2017","journal-title":"Neurol. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of miR-155 and BIC RNA in human B cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1825","article-title":"BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas","volume":"207","author":"Kluiver","year":"2005","journal-title":"J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.leukres.2010.05.007","article-title":"The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia","volume":"35","author":"Coskun","year":"2011","journal-title":"Leuk. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3324\/haematol.2010.023481","article-title":"Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia","volume":"95","author":"Schotte","year":"2010","journal-title":"Haematologica"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1007\/s13277-015-3203-y","article-title":"miR expression in MYC-negative DLBCL\/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B\u2013cell lymphoma","volume":"36","author":"Zajdel","year":"2015","journal-title":"Tumor Boil."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1182\/blood-2010-09-308684","article-title":"Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system","volume":"117","author":"Baraniskin","year":"2011","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2169\/internalmedicine.52.8531","article-title":"Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy","volume":"52","author":"Ohe","year":"2013","journal-title":"Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-510X(92)90065-S","article-title":"Autopsy report of primary CNS B-cell lymphoma indistinguishable from multiple sclerosis: Diagnosis with the immunoglobulin gene rearrangements analysis","volume":"111","author":"Kuroda","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11481-018-9779-4","article-title":"Exosomal miR-9 Released from HIV Tat Stimulated Astrocytes Mediates Microglial Migration","volume":"13","author":"Yang","year":"2018","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.celrep.2016.09.088","article-title":"A Nuclear Role for miR-9 and Argonaute Proteins in Balancing Quiescent and Activated Neural Stem Cell States","volume":"17","author":"Katz","year":"2016","journal-title":"Cell Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nn.3082","article-title":"microRNA-9 regulates axon extension and branching by targeting Map1b in mouse cortical neurons","volume":"15","author":"Bonev","year":"2012","journal-title":"Nat. Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2010.03.054","article-title":"Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation","volume":"476","author":"Pogue","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.stem.2017.08.002","article-title":"MicroRNAs Induce a Permissive Chromatin Environment that Enables Neuronal Subtype-Specific Reprogramming of Adult Human Fibroblasts","volume":"21","author":"Abernathy","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.celrep.2016.03.090","article-title":"Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells","volume":"15","author":"Topol","year":"2016","journal-title":"Cell Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.9758\/cpn.2016.14.3.256","article-title":"Investigation of Dysregulation of Several MicroRNAs in Peripheral Blood of Schizophrenia Patients","volume":"14","author":"Camkurt","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.15252\/embj.201387576","article-title":"Micro RNA -125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer\u2019s disease","volume":"33","author":"Benito","year":"2014","journal-title":"EMBO J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nn.3113","article-title":"An unconventional role for miRNA: Let-7 activates Toll-like receptor 7 and causes neurodegeneration","volume":"15","author":"Lehmann","year":"2012","journal-title":"Nat. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Derkow, K., Rossling, R., Schipke, C., Kruger, C., Bauer, J., Fahling, M., Stroux, A., Schott, E., Ruprecht, K., and Peters, O. (2018). Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0200602"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/cdd.2015.153","article-title":"MicroRNA-125b regulates microglia activation and motor neuron death in ALS","volume":"23","author":"Parisi","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","article-title":"The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease","volume":"28","author":"Packer","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40364-017-0104-9","article-title":"Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke","volume":"5","author":"Nygaard","year":"2017","journal-title":"Biomark. Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Long, G., Wang, F., Li, H., Yin, Z., Sandip, C., Lou, Y., Wang, Y., Chen, C., and Wang, D.W. (2013). Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans. BMC Neurol., 13.","DOI":"10.1186\/1471-2377-13-178"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"34512","DOI":"10.1038\/srep34512","article-title":"Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms","volume":"6","author":"Freiesleben","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/modpathol.2009.10","article-title":"Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma","volume":"22","author":"Robertus","year":"2009","journal-title":"Mod. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/neuonc\/nor107","article-title":"Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas","volume":"13","author":"Fischer","year":"2011","journal-title":"Neuro-Oncology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1177\/0300060518777399","article-title":"Prognostic impact of miR-196a\/b expression in adult acute myeloid leukaemia: A single-centre, retrospective cohort study","volume":"46","author":"Zhang","year":"2018","journal-title":"J. Int. Med Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Takashima, Y., Kawaguchi, A., Iwadate, Y., Hondoh, H., Fukai, J., Kajiwara, K., Hayano, A., and Yamanaka, R. (2019). MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210400"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11060-012-0908-2","article-title":"MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma","volume":"109","author":"Baraniskin","year":"2012","journal-title":"J. Neuro-Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1177\/1352458516684213","article-title":"miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands","volume":"23","author":"Quintana","year":"2017","journal-title":"Mult. Scler. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"20829","DOI":"10.18632\/oncotarget.4096","article-title":"A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies","volume":"6","author":"Drusco","year":"2015","journal-title":"Oncotarget"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/neuonc\/nos074","article-title":"MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity","volume":"14","author":"Teplyuk","year":"2012","journal-title":"Neuro-Oncology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bjc.2012.294","article-title":"Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation","volume":"107","author":"Hall","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Kakimoto, Y., Tanaka, M., Kamiguchi, H., Ochiai, E., and Osawa, M. (2016). MicroRNA Stability in FFPE Tissue Samples: Dependence on GC Content. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163125"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"29103","DOI":"10.3390\/ijms161226150","article-title":"Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies","volume":"16","author":"Shalaby","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"110118","DOI":"10.18632\/oncotarget.22654","article-title":"Proteomic changes in cerebrospinal fluid from primary central nervous system lymphoma patients are associated with protein ectodomain shedding","volume":"8","author":"Brocksieper","year":"2017","journal-title":"Oncotarget"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2009.07.029","article-title":"The role of the blood\u2013CNS barrier in CNS disorders and their treatment","volume":"37","author":"Palmer","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jns.2017.08.2733","article-title":"Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes","volume":"381","author":"Yagi","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s13402-012-0089-1","article-title":"Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours","volume":"35","author":"Cookson","year":"2012","journal-title":"Cell. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/bjc.2011.588","article-title":"Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma","volume":"106","author":"Konishi","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1373\/clinchem.2014.221341","article-title":"Circulating microRNA biomarker studies: Pitfalls and potential solutions","volume":"61","author":"Witwer","year":"2015","journal-title":"Clin. Chem."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/11\/1647\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:29:17Z","timestamp":1760189357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/11\/1647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":58,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["cancers11111647"],"URL":"https:\/\/doi.org\/10.3390\/cancers11111647","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]}}}